Literature DB >> 8654497

Blood-retinal barrier breakdown following experimental retinal ischemia and reperfusion.

C A Wilson1, B A Berkowitz, H Funatsu, D C Metrikin, D W Harrison, M K Lam, P L Sonkin.   

Abstract

The purpose of this study was to examine the effects of acute ischemia and reperfusion on blood-retinal barrier (BRB) function in the rabbit eye. Hydrostatic pressure (140 mmHg) was used to create total retinal ischemia for intervals of 20, 40, 60, 80 or 100 min in the rabbit eye. The location, size and permeability-surface-area product normalized to the area of retinal leakage (PS') of ischemia-induced BRB lesions were then measured using contrast-enhanced magnetic resonance imaging (MRI) after various intervals of reperfusion. Diffuse outer BRB leakage occurred in most eyes subjected to 80 or 100 min of ischemia. A posterior region of outer BRB sparing was found in eyes that underwent lesser durations of ischemia. On day 1 after retinal ischemia, a linear relationship was found between mean PS' and duration of ischemia for periods of ischemia between 20 and 100 min [slope: 5.65 x 10(-6) to 5.96 x 10(-6) cm min-1 (min ischemia)-1; r2 > or = 0.69]. Lesion size also increased between 20 and 100 min of ischemia. In a longitudinal study, eyes exposed to 60 min of ischemia showed a decrease in PS' and a lesion size over an 8-week period of observation. However, leakage was still present on post-ischemia day 57 in two of three eyes examined. Data obtained in these experiments are expected to prove useful in future studies aimed at understanding how BRB damage relates to neuroretinal damage after ischemia-reperfusion injury.

Entities:  

Mesh:

Year:  1995        PMID: 8654497     DOI: 10.1016/s0014-4835(05)80048-x

Source DB:  PubMed          Journal:  Exp Eye Res        ISSN: 0014-4835            Impact factor:   3.467


  8 in total

Review 1.  Molecular imaging of retinal disease.

Authors:  Megan E Capozzi; Andrew Y Gordon; John S Penn; Ashwath Jayagopal
Journal:  J Ocul Pharmacol Ther       Date:  2013-02-19       Impact factor: 2.671

Review 2.  Connexins in Cardiovascular and Neurovascular Health and Disease: Pharmacological Implications.

Authors:  Luc Leybaert; Paul D Lampe; Stefan Dhein; Brenda R Kwak; Peter Ferdinandy; Eric C Beyer; Dale W Laird; Christian C Naus; Colin R Green; Rainer Schulz
Journal:  Pharmacol Rev       Date:  2017-10       Impact factor: 25.468

3.  Evaluation of the aldose reductase inhibitor fidarestat on ischemia-reperfusion injury in rat retina.

Authors:  Irina G Obrosova; Yury Maksimchyk; Pal Pacher; Elisabet Agardh; Maj-Lis Smith; Azza B El-Remessy; Carl-David Agardh
Journal:  Int J Mol Med       Date:  2010-07       Impact factor: 4.101

Review 4.  MRI in ocular drug delivery.

Authors:  S Kevin Li; Martin J Lizak; Eun-Kee Jeong
Journal:  NMR Biomed       Date:  2008-11       Impact factor: 4.044

5.  Remote Ischemic Post-Conditioning Therapy is Protective in Mouse Model of Traumatic Optic Neuropathy.

Authors:  Muhammad Nadeem; Adam Kindelin; Laura Mahady; Kanchan Bhatia; Md Nasrul Hoda; Andrew F Ducruet; Saif Ahmad
Journal:  Neuromolecular Med       Date:  2020-11-13       Impact factor: 3.843

6.  All-trans-Retinaldehyde Contributes to Retinal Vascular Permeability in Ischemia Reperfusion.

Authors:  Alyssa Dreffs; Cheng-Mao Lin; Xuwen Liu; Sumathi Shanmugam; Steven F Abcouwer; Timothy S Kern; David A Antonetti
Journal:  Invest Ophthalmol Vis Sci       Date:  2020-06-03       Impact factor: 4.799

Review 7.  Cellular Stress Response and Immune Signaling in Retinal Ischemia-Reperfusion Injury.

Authors:  Gillipsie Minhas; Jyoti Sharma; Nooruddin Khan
Journal:  Front Immunol       Date:  2016-10-24       Impact factor: 7.561

8.  Neuroprotective effect of minocycline on rat retinal ischemia-reperfusion injury.

Authors:  Xiaoli Li; Zhiqiang Ye; Shuaili Pei; Dongliang Zheng; Lin Zhu
Journal:  Mol Vis       Date:  2021-07-08       Impact factor: 2.367

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.